Molecular mechanisms of the juvenile form of Batten disease: important role of MAPK signaling pathways (ERK1/ERK2, JNK and p38) in pathogenesis of the malady
Abstract Background Mutations in the CLN3 gene lead to so far an incurable juvenile-onset neuronal ceroid lipofuscinosis (JNCL) or Batten disease that starts at the age of 4–6 years with a progressive retinopathy leading to blindness. Motor disturbances, epilepsy and dementia manifest during several...
Main Authors: | Elena K. Shematorova, Dmitry G. Shpakovski, Anna D. Chernysheva, George V. Shpakovski |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-09-01
|
Series: | Biology Direct |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13062-018-0212-y |
Similar Items
-
The CLN3 gene and protein: What we know
by: Myriam Mirza, et al.
Published: (2019-12-01) -
Current Insights in Elucidation of Possible Molecular Mechanisms of the Juvenile Form of Batten Disease
by: Elena K. Shematorova, et al.
Published: (2020-10-01) -
in vivo localization of the neuronal ceroid lipofuscinosis proteins, CLN3 and CLN7, at endogenous expression levels
by: Alamin Mohammed, et al.
Published: (2017-07-01) -
Discovery of a CLN7 model of Batten disease in non-human primates
by: Jodi L. McBride, et al.
Published: (2018-11-01) -
Recent Insights into NCL Protein Function Using the Model Organism <i>Dictyostelium discoideum</i>
by: Meagan D. McLaren, et al.
Published: (2019-02-01)